Home › News and Press › Press releases

News and Press releases

View all News Press releases

Oxcia AB (publ) announces outcome of rights issue: 63% subscription rate

June 27, 2025 · Press releases

Oxcia enters a research collaboration with LEO Pharma to explore OXC-101 in medical dermatology

June 23, 2025 · News

New findings show OXC-101 may be effective against allergic asthma

June 5, 2025 · Press releases

Oxcia AB Publishes Annual Report for 2024

May 27, 2025 · Press releases

Notice of General Meeting

May 21, 2025 · Press releases

Notice of Extraordinary General Meeting

· Press releases

Oxcia AB Publishes Year-End Report for 2024

February 21, 2025 · Press releases

OXC-101 has been granted ODD status by the FDA in AML

February 20, 2025 · Press releases

Oxcia appoints Eva Sjökvist Saers as Chairman of the Board

February 5, 2025 · Press releases

Data presented for OXC-101 for a new indication – psoriasis

January 29, 2025 · Press releases

Professor Helleday presents new data on OXC-101 for psoriasis

January 23, 2025 · Press releases

Oxcia AB (publ) publishes interim report for the third quarter 2024

November 22, 2024 · Press releases

Search